Key Moments
#59–Jason Fung, M.D: Fasting as an antidote to obesity, insulin resistance, T2D, & metabolic illness
Peter Attia MDKey Moments
Dr. Jason Fung advocates fasting as a potent antidote to obesity, insulin resistance, and type 2 diabetes by addressing hyperinsulinemia and cellular overflow.
Key Insights
Conventional understanding of insulin resistance is flawed; it's an 'overflow problem' (cells crammed with glucose/fat) not 'underfill' (cells starved of glucose).
Hyperinsulinemia, not just hyperglycemia, drives metabolic syndrome (obesity, T2D, high triglycerides, low HDL, high blood pressure) and necessitates treatment.
Fasting is a highly effective, efficient, and free intervention to lower insulin, clear cellular glucose/fat, and reverse type 2 diabetes.
Type 2 diabetes is reversible, stemming from fatty liver (insulin resistance) and fatty pancreas (beta-cell failure), both caused by hyperinsulinemia.
Medical Bariatrics (fasting) offers similar benefits to bariatric surgery by reducing fat in organs and lowering insulin levels, without surgical risks.
Chronic diseases like cardiovascular disease and cancer are viewed as 'diseases of too much growth', linked to overactive nutrient sensing pathways (insulin, mTOR, AMPK).
Individualized approaches to fasting, considering patient condition, age, and willingness, are crucial for successful therapeutic outcomes.
THE FLAWED PARADIGM OF INSULIN RESISTANCE
Dr. Jason Fung challenges the conventional 'lock and key' understanding of insulin resistance, which posits cells are resistant to insulin acting as a key to allow glucose entry. This theory fails to explain why, in a state of insulin resistance, certain insulin functions (like de novo lipogenesis in the liver and mitogenic effects) remain highly sensitive, even super-sensitive. He argues it's impossible for the same cell to be both resistant and super-sensitive to the same hormone simultaneously, highlighting a central paradox in the prevailing model.
REDEFINING INSULIN RESISTANCE: THE OVERFLOW PROBLEM
Fung proposes an 'overflow paradigm' to explain insulin resistance, suggesting that cells do not take in glucose not because the 'gate is closed,' but because they are already 'too full.' This saturation, primarily with glucose and fat, prevents further entry. This reinterpretation resolves the paradox, as the highly active de novo lipogenesis and fat accumulation observed in type 2 diabetes are consistent with cells attempting to process and remove excess nutrients, rather than being internally starved. The fundamental issue shifts from insulin resistance to chronic hyperinsulinemia.
HYPERINSULINEMIA: THE ROOT OF METABOLIC SYNDROME
The discussion expands to frame metabolic syndrome—encompassing high blood glucose, abdominal obesity, high triglycerides, low HDL, and high blood pressure—as a syndrome of hyperinsulinemia. Excessive insulin drives the storage of glucose into fat, leading to fatty liver. This, in turn, causes the liver to export surplus fat as VLDL and triglycerides, contributing to high blood fats and accumulation in other organs, including the pancreas (fatty pancreas) and omentum (abdominal obesity). Insulin's effect on sodium reabsorption also elevates blood pressure, linking all facets of metabolic syndrome to persistently high insulin.
CONVENTIONAL DIABETES TREATMENTS: AGGRAVATING THE PROBLEM
Current pharmacological approaches for type 2 diabetes, such as sulfonylureas and exogenous insulin, aim to force more glucose into already saturated cells by increasing insulin levels. Dr. Fung likens this to 'shoving more shirts into an already full suitcase.' While these treatments may temporarily lower blood glucose, they worsen the underlying overflow problem, leading to increased insulin resistance, weight gain, and disease progression, rather than actual reversal. This explains why trials focusing solely on glycemic control often fail to show improvements in macrovascular outcomes.
SGLT2 INHIBITORS: A NEW PARADIGM IN DIABETES TREATMENT
SGLT2 inhibitors are presented as a novel class of drugs that align with the 'overflow paradigm.' Instead of forcing glucose into cells, they promote its excretion through urine, effectively 'emptying the suitcase.' Despite modest effects on A1c, these drugs have demonstrated significant protective effects against kidney and heart disease, which previous insulin-boosting medications failed to achieve. This supports the idea that addressing whole-body glucose burden, not just blood glucose levels, is key to treating the true pathology of metabolic disease.
THE PROTECTIVE NATURE OF OBESITY AND INSULIN RESISTANCE
Obesity and insulin resistance are reframed as the body's protective mechanisms against excessive glucose and insulin. When cells become saturated, developing 'resistance' is a defense against further overload. Similarly, adiposity serves to store excess energy safely, preventing lipotoxicity in vital organs. This view aligns with observations in lipodystrophy, where individuals lacking adipose tissue suffer severe insulin resistance due to fat accumulating in the liver and other critical organs. Even the glycouria in uncontrolled diabetes is seen as the body's attempt to excrete surplus sugar.
TYPE 2 DIABETES REVERSIBILITY: ADDRESSING FATTY LIVER AND PANCREAS
Type 2 diabetes is a two-step process involving hyperinsulinemia and beta-cell failure. Dr. Fung proposes that beta-cell failure isn't organ atrophy but rather 'fatty pancreas,' where fat clogs the organ, impairing insulin production. This 'twin cycles hypothesis' explains why diabetes is almost entirely reversible with interventions like bariatric surgery or fasting, which reduce fat in both the liver and pancreas. The rapid reversal often seen post-bariatric surgery, even before significant weight loss, supports the idea that clearing organ fat is the primary mechanism.
FASTING: THE ULTIMATE TOOL FOR INSULIN REDUCTION
Fasting is emphasized as the most potent method to lower insulin levels, enabling the body to deplete stored glucose and fat. It forces the body to switch to fat oxidation, effectively clearing out cellular overload, particularly from the liver and pancreas. This therapeutic approach, referred to as 'Medical Bariatrics,' can achieve similar rapid and profound reversals of type 2 diabetes as bariatric surgery, without invasive procedures. The simplicity and accessibility of fasting make it a powerful, underutilized intervention.
THE 'WHEN TO EAT' FACTOR: TIME-RESTRICTED FEEDING
Beyond 'what to eat,' Dr. Fung highlights 'when to eat' as a crucial, often overlooked, aspect of diet. He critiques the modern pattern of constant eating, advocating for time-restricted feeding as a practical first step. By compressing the eating window (e.g., 16:8 or 'one meal a day'), patients naturally reduce caloric intake and extend periods of low insulin, allowing the body to begin clearing excess nutrients. This approach is often easier for patients to adopt than complex dietary restrictions, especially in cultures with ingrained food traditions.
INDIVIDUALIZED FASTING PROTOCOLS: CATERING TO PATIENT NEEDS
Dr. Fung's clinical practice utilizes highly individualized fasting protocols, ranging from short time-restricted eating to multi-day water-only fasts. The intensity and duration depend on the patient's disease severity, age, co-morbidities, and willingness. For severe cases, such as non-healing diabetic foot ulcers, aggressive fasting (e.g., a week-long fast followed by 36-hour fasts thrice weekly) can lead to remarkably rapid healing and diabetes reversal, demonstrating the power of clearing systemic glucose overload.
MANAGING CHALLENGES OF FASTING: EXPECTATION AND SUPPORT
Anticipating and addressing common challenges like hunger, headaches, cramps, and sleep disturbances is crucial for patient success during fasting. Educating patients on what to expect normalizes these temporary symptoms, building trust and confidence. Providing a supportive environment, whether through family, community, or medical team, significantly enhances adherence, mirroring the success of religious fasting practices like Ramadan where communal support is inherent. Electrolyte monitoring is done, but physiological derangements requiring intervention are rare in his experience.
MUSCLE PRESERVATION DURING FASTING: CLINICAL OBSERVATIONS
Contrary to common concerns, Dr. Fung's extensive clinical experience with thousands of patients undergoing therapeutic fasting suggests that actual muscle mass loss is not a significant problem, particularly in obese individuals. He argues the body is not 'stupid' enough to prioritize burning muscle over abundant fat stores. Protein loss during fasting, which contributes to gluconeogenesis and autophagy, may in fact be beneficial in reducing superfluous connective tissue and skin, an observation supported by reduced prevalence of excess skin post-weight loss via fasting compared to chronic calorie restriction.
FASTING FOR HEALTHY INDIVIDUALS: PREVENTATIVE BENEFITS
Fasting offers preventative benefits even for healthy, non-diabetic, and non-obese individuals. Periodic insulin reduction through moderate fasting (e.g., daily time-restricted eating, occasional longer fasts) can lower the risk of chronic diseases linked to hyperinsulinemia and excessive growth, such as heart disease, stroke, cancer, Alzheimer's, and type 2 diabetes. While robust evidence for these specific longevity outcomes in healthy populations is still developing, the low risk-to-reward ratio of occasional fasting makes it a compelling lifestyle recommendation for long-term health.
CRITICAL EVALUATION OF EVIDENCE AND PRACTICALITY IN MEDICINE
Fung advocates for an approach to medicine that prioritizes clinical efficacy and practical implementation over rigid adherence to 'evidence-based medicine' that can be slow-moving and biased. He notes that highly dogmatic views on diet or treatment often come from those not directly treating patients, as diverse patient responses quickly disabuse one of universal solutions. For fasting, the historically widespread practice and low inherent risks, combined with clinically observed benefits, justify its therapeutic use, even as formal research catches up.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Organizations
●Books
●Drugs & Medications
●Studies Cited
●Concepts
●People Referenced
Common Questions
Physics advances through theories that explain anomalies and make wild predictions, which are then tested experimentally. Medicine, however, relies heavily on evidence-based consensus, which often leads to slow, glacial progress and a reluctance to adopt new theories that don't fit existing paradigms.
Topics
Mentioned in this video
One of Jason Fung's books focusing on understanding obesity.
One of Jason Fung's books, offering a comprehensive guide to fasting practices.
One of Jason Fung's books focusing on understanding and reversing type 2 diabetes.
One of Jason Fung's books on longevity.
A journal where Jason Fung published a case report on three patients reversing type 2 diabetes with fasting protocols.
Co-founded by Jason Fung, this program focuses on using dietary strategies like fasting to treat metabolic disease.
One of the institutions where Richard Feynman taught, mentioned in relation to his explanation of the scientific method.
An organization whose changing guidelines on low-carbohydrate diets highlight the slow movement of consensus-based medicine.
A prominent medical journal where Sam Klein's study on liposuction and insulin resistance was published.
Cited as reporting on papers about lipodystrophy, a condition where lack of fat storage leads to severe insulin resistance.
Mentioned as an organization that issues dietary guidelines.
Where Jason Fung completed his medical degree.
One of the institutions where Richard Feynman taught, mentioned in relation to his explanation of the scientific method.
Mentioned alongside other organizations that issue dietary guidelines that tend to change in five-year cycles.
Where Jason Fung completed his residency in nephrology.
Newton's theory is used as an example of a good scientific theory that explains a lot but is eventually refined or supplanted by better theories that explain anomalies.
Co-founder of Twitter, mentioned as a public figure who practices 24-hour fasting, which receives disproportionate media attention.
A nephrologist in Toronto, Canada, and a vocal critic of conventional approaches to type 2 diabetes treatment. He co-founded the Intensive Dietary Management program and is the author of several books on obesity, diabetes, fasting, and longevity.
Physicist whose theoretical advances are highlighted as an example of progress in science, contrasting with the slower pace of medicine.
Host of The Drive podcast, a physician with a focus on performance, health, and longevity.
A physician whose work on early detection of hyperinsulinemia through insulin levels is referenced.
A researcher known for developing the Fasting Mimicking Diet (FMD), a specific type of intermittent fasting protocol.
A renowned physicist praised for his elegant explanation of the scientific method, whose approach is compared to medicine.
A researcher known for the Counterpoint study, which showed the reversibility of type 2 diabetes by unclogging pancreatic fat.
A physicist whose work on quantum theory is mentioned in the context of scientific progress and theoretical advancements.
A study that found mixed results for different diets (low-fat vs. low-carb) on individuals, emphasizing individual variability in response.
Used during fasting to provide salt and other nutrients, especially for patients experiencing dizziness or certain side effects.
A supplement recommended to patients during fasting to calm adrenal glands and reduce sympathetic outflow, aiding sleep.
An over-the-counter supplement, even in its peripheral form, suggested to reduce sympathetic tone during fasting to improve sleep.
A study referenced to show that people can survive on very low salt intake, suggesting healthy kidneys can reabsorb necessary sodium during fasting.
A study published in the New England Journal of Medicine on liposuction failing to improve insulin resistance, leading to debate about subcutaneous vs. visceral fat.
A 2009 study showing that high fructose intake can lead to type 2 diabetes by specifically causing fat accumulation in the liver.
The site in the kidney where insulin causes sodium reabsorption, affecting blood pressure.
A specific type of intermittent fast developed by Valter Longo, involving caloric restriction over several days, discussed for its potential longevity benefits.
A hypothesis proposing that type 2 diabetes is caused by excess fat in the liver and pancreas, which fasting helps to reverse.
A newer class of drugs for diabetic kidney disease that makes patients excrete sugar through urine, showing protective effects against kidney and heart disease, unlike older anti-diabetic drugs.
Cited as an example of a major advance in medicine, accounting for a large percentage of progress.
A class of drugs mentioned as the last significant advance in slowing kidney disease progression before SGLT2 inhibitors.
More from Peter Attia MD
View all 322 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free